Verastem, Inc. Equity-NMS: VSTM

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Error in Fetching Data, Please retry later.
Previous close :$5.84
Open :$5.57
Today's high :$5.77
Today's low :$5.39
52W low :$2.1
52W high :$13.52
EPS(TTM): :-3.66
Shares O/S :51.49 M
Market cap :293.47 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Verastem, Inc. $5.7 -0% - 293.47M

Frequently Asked Questions

What is the share price of Verastem, Inc. today?

Verastem, Inc. (VSTM) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Verastem, Inc.

Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition. The Company’s advanced product candidates, avutometinib and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors, including low-grade serous ovarian cancer (LGSOC), non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer (CRC), and melanoma. Avutometinib is an orally available small molecule RAF/MEK clamp that inhibits the ras sarcoma (RAS)/RAF/MEK, ERK mitogen activated pathway kinase (MAPK) pathway. Defactinib is an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase (PYK2).